Kathy J Warden - Net Worth and Insider Trading
Kathy J Warden Net Worth
The estimated net worth of Kathy J Warden is at least $57 Million dollars as of 2023-09-23. Kathy J Warden is the Chair, CEO and President of Northrop Grumman Corp and owns about 134,583 shares of Northrop Grumman Corp (NOC) stock worth over $57 Million. Details can be seen in Kathy J Warden's Latest Holdings Summary section.
Transaction Summary of Kathy J Warden
Kathy J Warden Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kathy J Warden owns 3 companies in total, including Merck & Co Inc (MRK) , Northrop Grumman Corp (NOC) , and Merck & Co Inc (MRKPRB.PFD) .
Click here to see the complete history of Kathy J Warden’s form 4 insider trades.
Insider Ownership Summary of Kathy J Warden
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MRK | Merck & Co Inc | 2020-03-16 | director |
| NOC | Northrop Grumman Corp | 2013-01-01 | Corp VP & Pres Info Syst |
| MRKPRB.PFD | Merck & Co Inc | 2020-03-16 | director |
Kathy J Warden Latest Holdings Summary
Kathy J Warden currently owns a total of 1 stock. Kathy J Warden owns 134,583 shares of Northrop Grumman Corp (NOC) as of August 4, 2022, with a value of $57 Million.
Latest Holdings of Kathy J Warden
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NOC | Northrop Grumman Corp | 2022-08-04 | 134,583 | 424.90 | 57,184,317 |
Holding Weightings of Kathy J Warden
Kathy J Warden Form 4 Trading Tracker
According to the SEC Form 4 filings, Kathy J Warden has made a total of 2 transactions in Northrop Grumman Corp (NOC) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Northrop Grumman Corp is the sale of 10,000 shares on August 4, 2022, which brought Kathy J Warden around $5 Million.
Insider Trading History of Kathy J Warden
- 1
Kathy J Warden Trading Performance
GuruFocus tracks the stock performance after each of Kathy J Warden's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kathy J Warden is 5.67%. GuruFocus also compares Kathy J Warden's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kathy J Warden within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kathy J Warden's insider trading performs compared to the benchmark.
Performance of Kathy J Warden
Average Relative Return
5.51%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | 1.61 | 5.67 | 18.92 | 5.51 | 11.04 | 2.25 |
| Relative Return to S&P 500(%) | 0.52 | -2.88 | 14.22 | -4.35 | 2.92 | -8.59 |
Kathy J Warden Ownership Network
Ownership Network List of Kathy J Warden
Ownership Network Relation of Kathy J Warden
Kathy J Warden Owned Company Details
What does Merck & Co Inc do?
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Who are the key executives at Merck & Co Inc?
Kathy J Warden is the director of Merck & Co Inc. Other key executives at Merck & Co Inc include President & Human Health Int?l Joseph Romanelli , Chief Marketing Officer Chirfi Guindo , and SVP & U.S. Market Johannes Jacobus Oosthuizen .
Merck & Co Inc (MRK) Insider Trades Summary
Over the past 18 months, Kathy J Warden made no insider transaction in Merck & Co Inc (MRK). Other recent insider transactions involving Merck & Co Inc (MRK) include a net sale of 133,401 shares made by Steven Mizell , a net sale of 2,172,853 shares made by Kenneth C Frazier , and a net sale of 4,715 shares made by Joseph Romanelli .
In summary, during the past 3 months, insiders sold 8,839 shares of Merck & Co Inc (MRK) in total and bought 0 shares, with a net sale of 8,839 shares. During the past 18 months, 3,613,019 shares of Merck & Co Inc (MRK) were sold and 409 shares were bought by its insiders, resulting in a net sale of 3,612,610 shares.
Merck & Co Inc (MRK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Merck & Co Inc Insider Transactions
Kathy J Warden Mailing Address
Above is the net worth, insider trading, and ownership report for Kathy J Warden. You might contact Kathy J Warden via mailing address: 2980 Fairview Park Drive, Falls Church Va 22042.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
